» Articles » PMID: 35517717

Synthesis and Insight into the Structure-activity Relationships of 2-phenylbenzimidazoles As Prospective Anticancer Agents

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 6
PMID 35517717
Authors
Affiliations
Soon will be listed here.
Abstract

In order to explore and develop new anticancer agents, three series of 2-phenylbenzimidazoles, 15-46, were condensed under simple and mild conditions using sodium metabisulfite as an oxidation agent and another series, 47-55, were obtained a reduction reaction using sodium borohydride. All the compounds synthesized were evaluated for their anticancer activities against three human cancer cell lines. The novel compound 38 was found to be the most potent multi cancer inhibitor against A549, MDA-MB-231, and PC3 cell lines (IC values 4.47, 4.68 and 5.50 μg mL, respectively). In addition, compound 40 exhibited the best IC value of 3.55 μg mL against the MDA-MB-231 cell line. The results demonstrated that introducing a new substituent to compounds 37-55 could improve their antiproliferative activities.

Citing Articles

Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016-2023).

Hagar F, Abbas S, Atef E, Abdelhamid D, Abdel-Aziz M Mol Divers. 2024; 29(2):1821-1849.

PMID: 39031290 DOI: 10.1007/s11030-024-10907-8.


Study, Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives.

Karthick K, Abishek K, Angel Jemima E Bioinform Biol Insights. 2024; 18:11779322241247635.

PMID: 38854784 PMC: 11159556. DOI: 10.1177/11779322241247635.


Synthesis, DFT Calculations, Studies, and Antimicrobial Evaluation of Benzimidazole-Thiadiazole Derivatives.

Isik A, Acar Cevik U, Karayel A, Ahmad I, Patel H, Celik I ACS Omega. 2024; 9(16):18469-18479.

PMID: 38680334 PMC: 11044166. DOI: 10.1021/acsomega.4c00543.


Metal complexes of benzimidazole-derived as potential anti-cancer agents: synthesis, characterization, combined experimental and computational studies.

Nguyen V, Huynh T, Ho G, Nguyen T, Le Anh Nguyen T, Dao D R Soc Open Sci. 2022; 9(9):220659.

PMID: 36147940 PMC: 9490329. DOI: 10.1098/rsos.220659.

References
1.
Hoang T, Huynh T, Nguyen T . Synthesis, characterization, anti-inflammatory and anti-proliferative activity against MCF-7 cells of O-alkyl and O-acyl flavonoid derivatives. Bioorg Chem. 2015; 63:45-52. DOI: 10.1016/j.bioorg.2015.09.005. View

2.
Bauer J, Kinast S, Burger-Kentischer A, Finkelmeier D, Kleymann G, Abu Rayyan W . High-throughput-screening-based identification and structure-activity relationship characterization defined (S)-2-(1-aminoisobutyl)-1-(3-chlorobenzyl)benzimidazole as a highly antimycotic agent nontoxic to cell lines. J Med Chem. 2011; 54(19):6993-7. DOI: 10.1021/jm200571e. View

3.
Rangarajan M, Kim J, Sim S, Liu A, Liu L, LaVoie E . Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles. Bioorg Med Chem. 2000; 8(11):2591-600. DOI: 10.1016/s0968-0896(00)00188-7. View

4.
Mavrova A, Vuchev D, Anichina K, Vassilev N . Synthesis, antitrichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring. Eur J Med Chem. 2010; 45(12):5856-61. DOI: 10.1016/j.ejmech.2010.09.050. View

5.
White A, Curtin N, Eastman B, Golding B, Hostomsky Z, Kyle S . Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Bioorg Med Chem Lett. 2004; 14(10):2433-7. DOI: 10.1016/j.bmcl.2004.03.017. View